WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-0.99%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.4B
AUM Growth
-$393M
(-3.6%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
14.8%
Holding
711
New
186
Increased
182
Reduced
155
Closed
168
Top Buys
| 1 |
Marsh & McLennan
MMC
|
+$123M |
| 2 |
Electronic Arts
EA
|
+$102M |
| 3 |
Chord Energy
CHRD
|
+$100M |
| 4 |
Quest Diagnostics
DGX
|
+$89.2M |
| 5 |
Sensata Technologies
ST
|
+$73.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
+$138M |
| 2 |
Avnet
AVT
|
+$131M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$73.5M |
| 5 |
Amazon
AMZN
|
+$73.3M |
Sector Composition
| 1 | Healthcare | 42.62% |
| 2 | Technology | 19.87% |
| 3 | Energy | 7.88% |
| 4 | Industrials | 7.25% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Pliant Therapeutics
PLRX
$106M
| $1.11M | 0.01% |
103,623
+3,480
| +3% | +$37.4K |
|
452
Outlook Therapeutics
OTLK
$42M
| $1.11M | 0.01% |
+150,786
| New | +$1.11M |
|
453
Maplebear
CART
$11.9B
| $1.11M | 0.01% |
+34,602
| New | +$1.11M |
|
454
Fractyl Health
GUTS
$65.8M
| $1.11M | 0.01% |
259,548
+48,585
| +23% | +$207K |
|
455
Biomea Fusion
BMEA
$108M
| $1.06M | 0.01% |
236,419
-228,154
| -49% | -$1.03M |
|
|
BBOT
456
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$872M
| $1.06M | 0.01% |
103,247
-3,458
| -3% | -$35.3K |
|
457
General Dynamics
GD
$86.8B
| $1.03M | 0.01% |
+3,558
| New | +$1.03M |
|
458
Power Integrations
POWI
$2.52B
| $1M | 0.01% |
+14,299
| New | +$1M |
|
459
Kyverna Therapeutics
KYTX
$169M
| $997K | 0.01% |
132,900
-260,028
| -66% | -$1.95M |
|
460
Amylyx Pharmaceuticals
AMLX
$931M
| $995K | 0.01% |
523,772
| – | – |
|
461
TScan Therapeutics
TCRX
$107M
| $956K | 0.01% |
+163,492
| New | +$956K |
|
|
BLUE
462
DELISTED
bluebird bio
BLUE
| $954K | 0.01% |
48,467
-291
| -0.6% | -$5.73K |
|
463
Genpact
G
$7.71B
| $953K | 0.01% |
29,604
+9,760
| +49% | +$314K |
|
464
Intuit
INTU
$187B
| $932K | 0.01% |
+1,418
| New | +$932K |
|
465
Akamai
AKAM
$11.3B
| $921K | 0.01% |
+10,223
| New | +$921K |
|
|
SVCO
466
Silvaco Group
SVCO
$161M
| $899K | 0.01% |
+50,000
| New | +$899K |
|
467
Ventyx Biosciences
VTYX
$170M
| $876K | 0.01% |
+379,175
| New | +$876K |
|
468
Illumina
ILMN
$15.1B
| $855K | 0.01% |
+8,195
| New | +$855K |
|
469
Amplitude
AMPL
$1.5B
| $842K | 0.01% |
+94,642
| New | +$842K |
|
|
VIGL
470
DELISTED
Vigil Neuroscience
VIGL
| $826K | 0.01% |
+206,614
| New | +$826K |
|
471
MSC Industrial Direct
MSM
$5.17B
| $806K | 0.01% |
+10,159
| New | +$806K |
|
472
Apple
AAPL
$3.53T
| $805K | 0.01% |
3,821
-331,670
| -99% | -$69.9M |
|
473
N-able
NABL
$1.56B
| $775K | 0.01% |
50,883
+31,212
| +159% | +$475K |
|
474
Appian
APPN
$2.37B
| $774K | 0.01% |
+25,065
| New | +$774K |
|
475
Nektar Therapeutics
NKTR
$843M
| $772K | 0.01% |
+41,527
| New | +$772K |
|